HeartSciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 732.5%.

Top 15 shareholders own 15.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.32%	Mount Sinai School Of Medicine, Endowment Arm	48,549	US$145.2k	0%	0.07%
4.35%	John Matthews	39,726	US$118.8k	0%	no data
4%	John Adams	36,563	US$109.3k	0%	no data
0.7%	UBS Asset Management AG	6,396	US$19.1k	0%	no data
0.49%	Mark Hilz	4,457	US$13.3k	0.02%	no data
0.48%	Andrew Simpson	4,382	US$13.1k	0%	no data
0.25%	Morgan Stanley, Investment Banking and Brokerage Investments	2,290	US$6.8k	0%	no data
0.21%	The Vanguard Group, Inc.	1,915	US$5.7k	0%	no data
0.063%	Tower Research Capital Europe Limited	576	US$1.7k	-7.69%	no data
0.053%	Oliver Lagore Vanvalin Investment Group, Inc.	485	US$1.5k	-31%	no data
0.046%	Geode Capital Management, LLC	423	US$1.3k	0%	no data
0.0067%	Brian Szymczak	61	US$182.4	0%	no data
0.0019%	Bruce Bent	17	US$50.8	6.25%	no data
0.00044%	Bank of America Corporation, Asset Management Arm	4	US$12.0	0%	no data
0.00011%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	US$3.0	0%	no data